Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

Wednesday, May 24, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nautilus Biotechnology, Inc. announced its participation in two investor conferences in June 2023. The company will host a fireside chat at the Jefferies 2023 Healthcare Conference on June 8th and another at the Goldman Sachs 44th Annual Global Healthcare Conference on June 12th. These presentations aim to highlight Nautilus' advancements in single-molecule protein analysis and the potential impact on human health. Interested participants can access the webcasts through the company's website.
Price reaction · baseline $2.58 (2023-05-23 close) · hit after-hours · clean, no other NAUT news in the window
day 0 close · peak
+4.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in prestigious investor conferences increases visibility.
  • Fireside chats provide direct engagement with investors.
  • Nautilus' innovative platform could attract interest in proteomics.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences:
Jefferies 2023 Healthcare Conference in New York, NY
Fireside chat on Thursday, June 8th at 1:00 p.m. Eastern Time
Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA
Fireside chat on Monday, June 12th at 4:40 p.m. Pacific Time
Interested parties may access a live and archived webcast of the presentation on the company’s website on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Frequently Asked Questions

What investor conferences will Nautilus participate in?

Nautilus will participate in the Jefferies 2023 Healthcare Conference and Goldman Sachs 44th Annual Global Healthcare Conference.

When is Nautilus's fireside chat at Jefferies Conference?

The fireside chat at the Jefferies Conference is scheduled for June 8th at 1:00 p.m. ET.

How can I access Nautilus's conference presentations?

Live and archived webcasts of the presentations can be accessed on Nautilus’s website in the 'Investors' section.

Where is Nautilus Biotechnology headquartered?

Nautilus is headquartered in Seattle, with research and development located in the San Francisco Bay Area.

What is Nautilus's mission in proteomics?

Nautilus aims to democratize access to the proteome and drive advancements in human health.

ShareAdd on Google
Tags: NAUT Viatris Investor Conferences Healthcare Nautilus Biotechnology investor conference proteomics fireside chat
Last updated: May 24, 2023

Biotech snapshot

Cash runway
$143M liquidity · $4M/mo burn
~29 mo
Minimal dilution risk
Lead asset
MDMAPhase 2
Post-Traumatic Stress Disorder →